Neoadjuvant Therapy Improves Survival in Metastatic Colon Cancer
Among patients with metastatic colon cancer with liver or lung lesions who received neoadjuvant therapy, survival was longer in comparison with patients who received adjuvant therapy, but only in nonacademic settings.
Medscape Medical News
source https://www.medscape.com/viewarticle/984301?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/984301?src=rss
Comments
Post a Comment